BioRestorative Therapies (BRTX) Revenue (Gross) (2023 - 2025)
Historic Revenue (Gross) for BioRestorative Therapies (BRTX) over the last 3 years, with Q3 2025 value amounting to $59336.0.
- BioRestorative Therapies' Revenue (Gross) fell 6412.81% to $59336.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $367203.0, marking a year-over-year decrease of 5895.7%. This contributed to the annual value of $623801.0 for FY2024, which is 961.8% up from last year.
- BioRestorative Therapies' Revenue (Gross) amounted to $59336.0 in Q3 2025, which was down 6412.81% from $73743.0 recorded in Q2 2025.
- BioRestorative Therapies' 5-year Revenue (Gross) high stood at $402202.0 for Q4 2023, and its period low was -$39292.0 during Q3 2023.
- Its 3-year average for Revenue (Gross) is $129886.1, with a median of $131325.0 in 2024.
- Data for BioRestorative Therapies' Revenue (Gross) shows a peak YoY increase of 52097.88% (in 2024) and a maximum YoY decrease of 6734.85% (in 2024) over the last 5 years.
- Over the past 3 years, BioRestorative Therapies' Revenue (Gross) (Quarter) stood at $402202.0 in 2023, then plummeted by 67.35% to $131325.0 in 2024, then plummeted by 54.82% to $59336.0 in 2025.
- Its Revenue (Gross) stands at $59336.0 for Q3 2025, versus $73743.0 for Q2 2025 and $102799.0 for Q1 2025.